Clinical Trial Update: Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination [Phase 2]

View source ↗

Summary

Phase 2 trial assessing dose, safety, and tolerability of a new smallpox vaccine in adults without prior vaccination; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• Unspecified smallpox vaccine (Emergent BioSolutions product)

Snippet

Sponsor: Emergent BioSolutions | Conditions: Smallpox | Phase 2 | Status: COMPLETED | Results posted: 2011-02-11